for at udvide
kategorilisten.
Søgning på underkategorier- og emner:
Bemærk: Kan ikke leveres før jul.
Breast Cancer examines the effects of the disease on women through all stages of treatment. It draws heavily on verbatim accounts of sufferers together with relevant findings and theories from scientific research.
Bemærk: Kan ikke leveres før jul.
Based on the National Academy of Sciences approach to quantitative risk assessment. Emphasizes how an accurate assessment of cancer risk must draw on a... Læs mere
Bemærk: Kan ikke leveres før jul.
Bemærk: Kan ikke leveres før jul.
Bemærk: Kan ikke leveres før jul.
This book focuses on issues in clinical practice and research that are of general interest. Further, the book enhancesthe current body of knowledge on diagnostics and patient treatment and offers valuable new perspectives on practical clinical issues.
Bemærk: Kan ikke leveres før jul.
Supplying the reader with state-of-the-art knowledge required in order to identify these cancers early and to treat them as effectively as possible, this book... Læs mere
Bemærk: Kan ikke leveres før jul.
This book retains the core contents of the successful first edition and covers all the practical issues related to prostate biopsy diagnosis in day-to-day practice.
Bemærk: Kan ikke leveres før jul.
When taken as a whole, alongside its companion volumes Stem Cells Heterogeneity – Novel Concepts, and Stem Cells Heterogeneity in Different Organs, these three books... Læs mere
Bemærk: Kan ikke leveres før jul.
This book describes the evolution of treatment in oncology through the lens of approximately 250 landmark clinical trials. Such major clinical trials for common malignancies including breast, prostate, lung, gastrointestinal, genitourinary, and gynecologic cancers are discussed.
Bemærk: Kan ikke leveres før jul.
This book provides, for the first time, a unified approach to the application of MRI in radiotherapy that incorporates both a physics and a... Læs mere
Bemærk: Kan ikke leveres før jul.
This book aims to educate nurses and advanced practice providers (APP’s) about known mutations, availability of targeted therapy and the management of patients with non-small cell lung cancer (NSCLC).
Bemærk: Kan ikke leveres før jul.
This book represents an up-dated summary of the state of the art of the characterization of cancer stem cell/ cancer initiating cell (CSC/CIC) properties.